IndieBio SFinIndieBioQ&A with the new Managing Director of IndieBio, Po BronsonWatching how we’ve gutted our industrial base has been painful. But I would argue the path forward is vividly clear.Sep 4, 2020Sep 4, 2020
IndieBio SFinIndieBioIntroducing IndieBio Class NineIndieBio helps entrepreneurs build ground-breaking biotech companies. We’re excited to share our ninth class of 11 new startups. They have…Nov 1, 2019Nov 1, 2019
IndieBio SFinIndieBioBeeline Therapeutics: Supercharging T-regsBeeline takes engineered immune cell therapy in a new direction. They are unique in how they have engineered regulatory T cells (Tregs)…Jun 25, 2019Jun 25, 2019
IndieBio SFinIndieBioCASPR Biotech: Revolutionizing Molecular DiagnosticsThe Crispr Cas complex has been a game-changing technology for gene editing. CASPR Biotech is using the incredible accuracy of CRISPR for…Jun 17, 2019Jun 17, 2019
IndieBio SFinIndieBioGavilan Biodesign: Overcoming Drug ResistanceGavilan Biodesign emerged out of the Donald Lab at Duke University, one of the world leaders in computational drug design. During their…Jun 13, 2019Jun 13, 2019
IndieBio SFinIndieBioThe State of the Art: In Silico Drug DevelopmentJust how well can computers model the complexity of living organisms?May 6, 2019May 6, 2019
IndieBio SFinIndieBioThe State of the Art: The MicroBiome is a Drug FactoryIt’s more than a “second brain” — it acts on all parts of the body.Apr 30, 2019Apr 30, 2019
IndieBio SFinIndieBioBest Practices for AcceleratorsAs accelerators proliferate, are they losing their edge?Mar 27, 2019Mar 27, 2019
IndieBio SFinIndieBioExecutive Summary of “The $100 Trillion Opportunity” Series, by Arvind GuptaMeeting the challenge of climate change is commonly characterized as a tradeoff with industrial economic growth. In order to save the…Jan 17, 2019Jan 17, 2019